Mesenchymal stem cell (MSC)-sourced secretome, defined as the set of MSC-derived
bioactive factors (soluble proteins, nucleic acids, lipids and extracellular vesicles), showed …

Results obtained from completed and on-going clinical studies indicate huge therapeutic
potential of stem cell-based therapy in the treatment of degenerative, autoimmune and …

Osteoarthritis (OA) is a chronic, prevalent, debilitating joint disease characterized by
progressive cartilage degradation, subchondral bone remodeling, bone marrow lesions …

The unique properties of mesenchymal stromal/stem cells (MSCs) to self-renew and their
multipotentiality have rendered them attractive to researchers and clinicians. In addition to …

The advent of mesenchymal stem cell (MSC)-based therapies for clinical therapeutics has
been an exciting and new innovation for the treatment of a variety of diseases associated …

The role of interleukin 1 receptor antagonist (IL1RA) in mediating the immunosuppressive
effect of mesenchymal stem/stromal cells (MSCs) has been reported in several studies …

Currently, the most effective therapy for acute liver failure and advanced cirrhosis is liver
transplantation. However, this procedure has several limitations, including lack of donors …

Mesenchymal stem cells (MSCs) are adult, self-renewable, multipotent cells that can be
found in almost all postnatal tissues. Because of their capacity for self-renewal and …

Stem cell‐based therapy is considered to be a new hope in transplantation medicine.
Among stem cells, mesenchymal stem cells (MSCs) are, due to their differentiation and …

Mesenchymal stem cells (MSCs) can exhibit a marked tropism towards site of tumors. Many
studies have reported that tumor progression and metastasis increase by MSCs. In contrast …